High expression of the stem cell marker nestin is an adverse prognostic factor in WHO grade II–III astrocytomas and oligoastrocytomas

By Hatanpaa Kimmo   Hu Tianshen   Vemireddy Vamsidhara   Foong Chan   Raisanen Jack   Oliver Dwight   Hiemenz Matthew   Burns Dennis   White Charles   Whitworth L.   Mickey Bruce   Stegner Martha   Habib Amyn   Fink Karen   Maher Elizabeth   Bachoo Robert  

Journal of Neuro-Oncology, Vol. 117, Iss. 1, 2014-03 ,pp. : 183-189

Springer Publishing Company

Access to resources Recommend Favorite

Stereotactic radiosurgery for WHO grade I meningiomas

By Sheehan Jason   Williams Brian   Yen Chun  

Journal of Neuro-Oncology, Vol. 99, Iss. 3, 2010-09 ,pp. : 407-416

Springer Publishing Company

Access to resources Recommend Favorite

Intracranial meningiomas of atypical (WHO grade II) histology

By Rogers Leland   Gilbert Mark   Vogelbaum Michael  

Journal of Neuro-Oncology, Vol. 99, Iss. 3, 2010-09 ,pp. : 393-405

Springer Publishing Company

Access to resources Recommend Favorite

The Efficacy of Radiation Therapy in the Management of Grade I Astrocytomas

By Kidd Elizabeth   Mansur David   Leonard Jeffrey   Michalski Jeff   Simpson Joseph   Perry Arie  

Journal of Neuro-Oncology, Vol. 76, Iss. 1, 2006-01 ,pp. : 55-58

Springer Publishing Company

Access to resources Recommend Favorite

Current concepts in the evaluation and management of WHO grade II gliomas

By Piepmeier Joseph  

Journal of Neuro-Oncology, Vol. 92, Iss. 3, 2009-05 ,pp. : 253-259

Springer Publishing Company

Access to resources Recommend Favorite